MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 84 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $353,806 | -19.1% | 43,951 | +9.1% | 0.00% | – |
| Q2 2023 | $437,484 | +8649.7% | 40,284 | +5285.6% | 0.00% | – |
| Q1 2023 | $5,000 | +249900.0% | 748 | +20.6% | 0.00% | – |
| Q4 2022 | $2 | -100.0% | 620 | -75.8% | 0.00% | – |
| Q3 2022 | $17,000 | +70.0% | 2,560 | +23.7% | 0.00% | – |
| Q2 2022 | $10,000 | -99.6% | 2,070 | -99.3% | 0.00% | – |
| Q1 2022 | $2,738,000 | -22.7% | 292,860 | -1.8% | 0.00% | – |
| Q4 2021 | $3,542,000 | -0.2% | 298,121 | -4.4% | 0.00% | – |
| Q3 2021 | $3,550,000 | +51.1% | 311,925 | +138.1% | 0.00% | – |
| Q2 2021 | $2,349,000 | -20.2% | 130,986 | -31.1% | 0.00% | – |
| Q1 2021 | $2,943,000 | +48.7% | 190,093 | +17.2% | 0.00% | – |
| Q4 2020 | $1,979,000 | -13.7% | 162,259 | -17.8% | 0.00% | – |
| Q3 2020 | $2,294,000 | – | 197,385 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 3,629,622 | $33,936,000 | 7.88% |
| VR Adviser, LLC | 3,156,803 | $29,516,000 | 4.78% |
| Bleichroeder LP | 1,322,463 | $12,365,000 | 2.19% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $13,380,000 | 1.30% |
| 683 Capital Management, LLC | 1,932,829 | $18,072,000 | 0.97% |
| Granite Point Capital Management, L.P. | 472,056 | $4,414,000 | 0.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,766,000 | $25,862,000 | 0.79% |
| Avoro Capital Advisors LLC | 3,150,000 | $29,453,000 | 0.54% |
| Artal Group S.A. | 1,000,000 | $9,350,000 | 0.39% |
| Stonepine Capital Management, LLC | 56,747 | $531,000 | 0.22% |